Clinical Trials Browser

Recruiting × Thyroid Carcinoma, Anaplastic × pembrolizumab × Clear all

NCT06374602 2025-09-05

Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer

Phase 2 Recruiting

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic